Geology ReportsSearch

USGS · 70025626

Clinical pathology and assessment of pathogen exposure in southern and Alaskan sea otters

Abstract

The southern sea otter ( Enhydra lutris nereis ) population in California (USA) and the Alaskan sea otter ( E. lutris kenyoni ) population in the Aleutian Islands (USA) chain have recently declined. In order to evaluate disease as a contributing factor to the declines, health assessments of these two sea otter populations were conducted by evaluating hematologic and/or serum biochemical values and exposure to six marine and terrestrial pathogens using blood collected during ongoing studies from 1995 through 2000. Samples from 72 free-ranging Alaskan, 78 free-ranging southern, and (for pathogen exposure only) 41 debilitated southern sea otters in rehabilitation facilities were evaluated and compared to investigate regional differences. Serum chemistry and hematology values did not indicate a specific disease process as a cause for the declines. Statistically significant differences were found between free-ranging adult southern and Alaskan population mean serum levels of creatinine kinase, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, calcium, cholesterol, creatinine, glucose, phosphorous, total bilirubin, blood urea nitrogen, and sodium. These were likely due to varying parasite loads, contaminant exposures, and physiologic or nutrition statuses. No free-ranging sea otters had signs of disease at capture, and prevalences of exposure to calicivirus, Brucella spp., and Leptospira spp. were low. The high prevalence (35%) of antibodies to Toxoplasma gondii in free-ranging southern sea otters, lack of antibodies to this parasite in Alaskan sea otters, and the pathogen's propensity to cause mortality in southern sea otters suggests that this parasite may be important to sea otter population dynamics in California but not in Alaska. The evidence for exposure to pathogens of public health importance (e.g., Leptospira spp., T. gondii ) in the southern sea otter population, and the naïveté of both populations to other pathogens (e.g., morbillivirus and Coccidiodes immitis ) may have important implications for their management and recovery.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K.D. Hanni, J.A.K. Mazet, F.M.D. Gulland, James A. Estes, M. Staedler, M.J. Murray, Melissa A. Miller, David A. Jessup. 2003. Clinical pathology and assessment of pathogen exposure in southern and Alaskan sea otters. https://doi.org/10.7589/0090-3558-39.4.837

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related USGS reports

Fipronil baits as emerging tools for flea control and plague mitigation: Experiments with cricetid mice on prairie dog colonies

Plague is a zoonotic disease of mammalian hosts and flea vectors. Wildlife biologists most commonly mitigate plague by controlling flea populations. We evaluated the efficacy of edible baits for systemic flea control with two cricetid species on colonies of black-tailed prairie dogs ( Cynomys ludovicianus ): the western deer mouse ( Peromyscus sonoriensis ) and the northern grasshopper mouse ( Onychomys leucogaster ). We tested grain bait with 0.005% fipronil by weight and “FipBit” pellets with 0.46–1.52 mg of fipronil/pellet. Flea prevalence was assessed via combing of live-trapped mice. In one experiment with fipronil grain bait and FipBits ( n =564 combings), flea prevalence declined from 74% (grain) and 45% (FipBits) before treatments to 0% for both treatments from 30–44 d and from 324–413 d after treatments. During a second experiment with FipBits ( n =299 combings), flea prevalence declined from 13% to 32% before treatments to 0% from 11–15 d after treatments, but increased to 29–56% from 349–378 d after treatments. Results herein suggest annual fipronil bait treatments may be most effective for flea control.

Journal of Wildlife Diseases

Toxoplasma gondii: Challenges and perspectives in interpreting longitudinal seroprevalence data for a chronic parasitic infection

Toxoplasma gondii —the causative agent of toxoplasmosis—is a zoonotic pathogen of warm-blooded hosts. Infection causes mild-to-severe symptoms, including lethargy, fever, muscle pain, abortion, ocular disease, and encephalitis. Toxoplasma affects many vertebrate species, although felids are the only known definitive hosts. Seroprevalence in wildlife is often assessed using cross-sectional data, but few studies have tracked individual-level infections through time. We present a 4-yr dataset from white-tailed deer ( Odocoileus virginianus ) with repeated sampling of individuals that highlights challenges associated with assigning serostatus to individuals. Using a modified agglutination test, we observed seroconversion from seronegative to seropositive within individuals, as expected. Although toxoplasmosis is known to be a chronic disease, we also found reversion from seropositive to seronegative. Accurate assignment of serostatus is necessary for evaluating effects of infection on behavioral and physiologic outcomes. However, longitudinal data from individuals whose titers oscillate around the positive threshold present novel challenges. Therefore, we discuss the implications for assigning serostatus for chronic toxoplasmosis infection for three proposed approaches: 1) ever positive, always positive; 2) negative until positive and then always positive; and 3) status by sampling period. Clarifying which approach is used to assign serostatus when analyzing longitudinal T. gondii data may enable more meaningful comparisons across systems and studies.

Journal of Wildlife Diseases

Mortality events in Yuma myotis (Myotis yumanensis) due to white-nose syndrome in Washington, USA

The impacts of white-nose syndrome (WNS) on many bat species in eastern North America have been well documented because of the length of time that the causative agent, Pseudogymnoascus destructans ( Pd ), has been present and the ability to monitor bat hibernacula in that region. However, the disease outcomes for bat species in western North America are less known because of the more recent arrival of Pd and the challenges associated with monitoring hibernating bat populations in parts of the western US. We report on mortality events involving Yuma myotis ( Myotis yumanensis ) bats at two locations in King and Benton counties, Washington, US, that were attributed to WNS during the late winters of 2020–21 and 2024, respectively. All bats that were grossly examined had depleted subcutaneous white adipose tissue, tested positive for the presence of Pd , had histopathologic lesions consistent with WNS, and did not exhibit evidence of other disease processes that may have contributed to death. Mortality was likely higher than what was documented because the locations of the Pd -contaminated hibernacula from which the bats originated were inaccessible or unknown and thus could not be surveyed. These findings indicate that Yuma myotis may be highly susceptible to WNS, and close monitoring is warranted to understand how WNS will affect population trends in this (and other) western bat species.

Washington